(Q50523267)

14 March 2018

title

Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis. (English)

1 reference

14 March 2018

0 references

1 reference

1 reference

Reyes-Moreno C

1

1 reference

14 March 2018

Sourla A

2

1 reference

14 March 2018

Choki I

3

1 reference

14 March 2018

Doillon C

4

1 reference

14 March 2018

Koutsilieris M

5

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

14 March 2018

published in

Urology

1 reference

14 March 2018

volume

52

1 reference

14 March 2018

issue

2

1 reference

14 March 2018

page(s)

341-347

1 reference

14 March 2018

Selective osteoblast mitogens can be extracted from prostatic tissue

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Effects of human prostatic mitogens on rat bone cells and fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Selective stimulation of prostatic carcinoma cell proliferation by transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Skeletal metastases in advanced prostate cancer: cell biology and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Endocrine therapy of prostate cancer: optimal form and timing

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Objective response and disease outcome in 59 patients with stage D2 prostatic cancer treated with either Buserelin or orchiectomy. Disease aggressivity and its association with response and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG-63 human osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

"Thymineless" death in androgen-independent prostatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Features of apoptotic cells measured by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

The androgen receptor gene mutations database

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Insulin-Like Growth Factor-1 Inhibition of Apoptosis Is Associated with Increased Expression of the bcl-xL Gene Product

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Apoptosis meets signal transduction: elimination of a BAD influence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900182-4

7 January 2021

10.1016/S0090-4295(98)00182-4

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018